#USA #Gryphon Investors #Naperville #Vetnique Labs #Noel Geoffroy

Vetnique Labs Welcomes Noel Geoffroy as Global CEO

Vetnique Labs, a prominent name in the pet health and wellness sector, has recently made headlines by appointing Noel Geoffroy as its new Global CEO. This strategic move is part of the company's growth plan, which is backed by Gryphon Investors, a well-respected private investment firm.

Noel Geoffroy comes to Vetnique with a wealth of experience from her previous roles at industry giants like Sanofi, Procter & Gamble, Kellogg, Heinz, and Helen of Troy. Her impressive track record encompasses leading global teams and effectively scaling brands during critical periods of transformation and growth.

Eddie Douglas, Managing Director at Gryphon, expressed enthusiasm about Geoffroy’s leadership: “We are thrilled to welcome Noel as the Global CEO of Vetnique. Her experience across consumer health, ability to build enduring brands, and commitment to mission-driven businesses give us strong conviction she will carry Vetnique's momentum forward.”

Established as a leading vet-recommended company, Vetnique Labs develops a diverse range of specialty pet products, including supplements and topical solutions targeting digestive health, joint health, allergy support, and ear care. The company’s Glandex brand is recognized as the #1 veterinarian-recommended digestive aid in the U.S. (excluding probiotics), while its YuMOVE line holds the top position in joint mobility supplements for pets in the U.K.

James Bascharon, the founder of Vetnique and previous CEO for North America operations, will continue to contribute as a board member and serve as a Strategic Advisor. Fiona Hope, who previously helmed the company’s operations for the U.K. and rest of the world, is parting ways to explore other opportunities.

Executive Chair Chris Slager noted the significance of this leadership transition, stating, “Today marks an important milestone for Vetnique as we take the next step in our mission to bring science-based solutions to pet health. We are deeply grateful to Fiona and James for their leadership in shaping Vetnique into the exciting business it is today.” He added, “Noel brings a proven track record of commercial success and a leadership style well-aligned with Vetnique's culture and upcoming growth phase.”

Geoffroy's passion for the pet health sector and her dedication to fostering a positive impact is reflected in her own words: “I am honored to join Vetnique's passionate team at such an exciting moment. The company's true obsession and relentless focus on helping pets thrive for life, backed by patented and science-backed products and veterinary credibility, immediately attracted me to this opportunity.”

Veterinary leadership and scientific backing form the backbone of Vetnique's operations, which are dedicated to delivering premium and effective solutions for pets and their caregivers. The company has gained the trust of over 125,000 veterinarians worldwide and has steadfastly supported the health and wellness of over 5 million pets each year.

Under Noel Geoffroy's stewardship, the future looks promising for Vetnique Labs as they continue to innovate and enhance their product offerings, ensuring pet parents can depend on their science-backed, vet-recommended solutions to keep their furry companions healthy and happy.

For more information on Vetnique and its products, visit their official website at Vetnique.com.

About Vetnique Labs

Vetnique Labs is a global company focused on pet wellness, offering scientifically backed and vet-formulated solutions designed to promote the health and longevity of pets. Their products are built upon a foundation of veterinary expertise and high-quality ingredients. The company is a rapidly growing player in the pet health sector, having garnered more than 200,000 five-star reviews from pet owners globally.

About Gryphon Investors

Gryphon Investors is a leading middle-market private equity firm dedicated to partnering with businesses across various sectors to drive competitive advantage and growth. Founded in 1999, the firm has managed assets exceeding $10 billion, demonstrating a robust commitment to accelerating value creation through its integrated approach to investment and operations.